VRK3-mediated inactivation of ERK signaling in adult and embryonic rodent tissues

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1783, Issue 1, 2008, Pages 49-58

  Kang, Tae Hong ^a   Kim, Kyong Tai ^a  

^a Biotechnology Research Center   (South Korea)

Author keywords

Extracellular signal regulated kinase; Mitogen activated protein kinase phosphatase; Vaccinia H1 related phosphatase; Vaccinia related kinase 3

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN SERINE THREONINE KINASE; UNCLASSIFIED DRUG; VACCINIA RELATED KINASE 3;

ANIMAL TISSUE; ARTICLE; CELL GROWTH; CONTROLLED STUDY; EMBRYO; EMBRYO CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME LOCALIZATION; ENZYME REGULATION; IMMUNOPRECIPITATION; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION;

AGING; ANIMALS; CELL LINE; DUAL SPECIFICITY PHOSPHATASE 3; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; MALE; MAP KINASE SIGNALING SYSTEM; MICE; ORGAN SPECIFICITY; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; RATS; RNA, SMALL INTERFERING;

RODENTIA;

EID: 38049016957     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2007.10.011     Document Type: Article

References (46)

1. Nichols R.J., and Traktman P. Characterization of three paralogous members of the Mammalian vaccinia related kinase family. J. Biol. Chem. 279 (2004) 7934-7946
2. Vega F.M., Gonzalo P., Gaspar M.L., and Lazo P.A. Expression of the VRK (vaccinia-related kinase) gene family of p53 regulators in murine hematopoietic development. FEBS Lett. 544 (2003) 176-180
3. Aihara H., Nakagawa T., Yasui K., Ohta T., Hirose S., Dhomae N., Takio K., Kaneko M., Takeshima Y., Muramatsu M., and Ito T. Nucleosomal histone kinase-1 phosphorylates H2A Thr 119 during mitosis in the early Drosophila embryo. Genes Dev. 18 (2004) 877-888
4. T.H. Kang, D.Y. Park, Y.H. Choi, K.J. Kim, H.S. Yoon, K.T. Kim, Mitotic histone H3 phosphorylation by VRK1 in mammalian cells, Mol. Cell. Biol. (2007), doi:10.1128/MCB.00018-07.
5. Nichols R.J., Wiebe M.S., and Traktman P. The vaccinia-related kinases phosphorylate the N′ terminus of BAF, regulating its interaction with DNA and its retention in the nucleus. Mol. Biol. Cell 17 (2006) 2451-2464
6. Lopez-Borges S., and Lazo P.A. The human vaccinia-related kinase 1 (VRK1) phosphorylates threonine-18 within the mdm-2 binding site of the p53 tumour suppressor protein. Oncogene 19 (2000) 3656-3664
7. Vega F.M., Sevilla A., and Lazo P.A. p53 Stabilization and accumulation induced by human vaccinia-related kinase 1. Mol. Cell. Biol. 24 (2004) 10366-10380
8. Sevilla A., Santos C.R., Vega F.M., and Lazo P.A. Human vaccinia-related kinase 1 (VRK1) activates the ATF2 transcriptional activity by novel phosphorylation on Thr-73 and Ser-62 and cooperates with JNK. J. Biol. Chem. 279 (2004) 27458-27465
9. Sevilla A., Santos C.R., Barcia R., Vega F.M., and Lazo P.A. c-Jun phosphorylation by the human vaccinia-related kinase 1 (VRK1) and its cooperation with the N-terminal kinase of c-Jun (JNK). Oncogene 23 (2004) 8950-8958
10. Blanco S., Klimcakova L., Vega F.M., and Lazo P.A. The subcellular localization of vaccinia-related kinase-2 (VRK2) isoforms determines their different effect on p53 stability in tumour cell lines. FEBS J. 273 (2006) 2487-2504
11. Kang T.H., and Kim K.T. Negative regulation of ERK activity by VRK3-mediated activation of VHR phosphatase. Nat. Cell Biol. 8 (2006) 863-869
12. Chambard J.C., Lefloch R., Pouyssegur J., and Lenormand P. ERK implication in cell cycle regulation. Biochim. Biophys. Acta 1773 (2007) 1299-1310
13. Aouadi M., Binetruy B., Caron L., Le Marchand-Brustel Y., and Bost F. Role of MAPKs in development and differentiation: lessons from knockout mice. Biochimie 88 (2006) 1091-1098
14. Costa M., Marchi M., Cardarelli F., Roy A., Beltram F., Maffei L., and Ratto G.M. Dynamic regulation of ERK2 nuclear translocation and mobility in living cells. J. Cell Sci. 119 (2006) 4952-4963
15. Pouyssegur J., Volmat V., and Lenormand P. Fidelity and spatio-temporal control in MAP kinase (ERKs) signalling. Biochem. Pharmacol. 64 (2002) 755-763
16. Bhalla U.S., Ram P.T., and Iyengar R. MAP kinase phosphatase as a locus of flexibility in a mitogen-activated protein kinase signaling network. Science 297 (2002) 1018-1023
17. Kondoh K., and Nishida E. Regulation of MAP kinases by MAP kinase phosphatases. Biochim. Biophys. Acta 1773 (2007) 1227-1237
18. Farooq A., and Zhou M.M. Structure and regulation of MAPK phosphatases. Cell. Signal. 16 (2004) 769-779
19. Brondello J.M., Pouyssegur J., and McKenzie F.R. Reduced MAP kinase phosphatase-1 degradation after p42/p44MAPK-dependent phosphorylation. Science 286 (1999) 2514-2517
20. Lin Y.W., Chuang S.M., and Yang J.L. ERK1/2 achieves sustained activation by stimulating MAPK phosphatase-1 degradation via the ubiquitin-proteasome pathway. J. Biol. Chem. 278 (2003) 21534-21541
21. Todd J.L., Tanner K.G., and Denu J.M. Extracellular regulated kinases (ERK) 1 and ERK2 are authentic substrates for the dual-specificity protein-tyrosine phosphatase VHR. A novel role in down-regulating the ERK pathway. J. Biol. Chem. 274 (1999) 13271-13280
22. Alonso A., Rahmouni S., Williams S., van Stipdonk M., Jaroszewski L., Godzik A., Abraham R.T., Schoenberger S.P., and Mustelin T. Tyrosine phosphorylation of VHR phosphatase by ZAP-70. Nat. Immunol. 4 (2003) 44-48
23. Groom L.A., Sneddon A.A., Alessi D.R., Dowd S., and Keyse S.M. Differential regulation of the MAP, SAP and RK/p38 kinases by Pyst1 a novel cytosolic dual-specificity phosphatase. Embo. J. 15 (1996) 3621-3632
24. Muda M., Theodosiou A., Rodrigues N., Boschert U., Camps M., Gillieron C., Davies K., Ashworth A., and Arkinstall S. The dual specificity phosphatases M3/6 and MKP-3 are highly selective for inactivation of distinct mitogen-activated protein kinases. J. Biol. Chem. 271 (1996) 27205-27208
25. Rahmouni S., Cerignoli F., Alonso A., Tsutji T., Henkens R., Zhu C., Louis-dit-Sully C., Moutschen M., Jiang W., and Mustelin T. Loss of the VHR dual-specific phosphatase causes cell-cycle arrest and senescence. Nat. Cell Biol. 8 (2006) 524-531
26. Sugiura R., Kita A., Shimizu Y., Shuntoh H., Sio S.O., and Kuno T. Feedback regulation of MAPK signalling by an RNA-binding protein. Nature 424 (2003) 961-965
27. Wilson M.J., Jeyasuria P., Parker K.L., and Koopman P. The transcription factors steroidogenic factor-1 and SOX9 regulate expression of Vanin-1 during mouse testis development. J. Biol. Chem. 280 (2005) 5917-5923
28. Chang L., and Karin M. Mammalian MAP kinase signalling cascades. Nature 410 (2001) 37-40
29. Santos S.D., Verveer P.J., and Bastiaens P.I. Growth factor-induced MAPK network topology shapes Erk response determining PC-12 cell fate. Nat. Cell Biol. 9 (2007) 324-330
30. Gille H., Kortenjann M., Thomae O., Moomaw C., Slaughter C., Cobb M.H., and Shaw P.E. ERK phosphorylation potentiates Elk-1-mediated ternary complex formation and transactivation. Embo. J. 14 (1995) 951-962
31. Hodge C., Liao J., Stofega M., Guan K., Carter-Su C., and Schwartz J. Growth hormone stimulates phosphorylation and activation of elk-1 and expression of c-fos, egr-1, and junB through activation of extracellular signal-regulated kinases 1 and 2. J. Biol. Chem. 273 (1998) 31327-31336
32. Bernal-Mizrachi E., Wen W., Srinivasan S., Klenk A., Cohen D., and Permutt M.A. Activation of Elk-1 an Ets transcription factor, by glucose and EGF treatment of insulinoma cells. Am. J. Physiol: Endocrinol. Metab. 281 (2001) E1286-E1299
33. Goruppi S., Bonventre J.V., and Kyriakis J.M. Signaling pathways and late-onset gene induction associated with renal mesangial cell hypertrophy. Embo. J. 21 (2002) 5427-5436
34. Yu H.Y., Inoguchi T., Nakayama M., Tsubouchi H., Sato N., Sonoda N., Sasaki S., Kobayashi K., and Nawata H. Statin attenuates high glucose-induced and angiotensin II-induced MAP kinase activity through inhibition of NAD(P)H oxidase activity in cultured mesangial cells. Med. Chem. 1 (2005) 461-466
35. Liu S., Liang Y., Huang H., Wang L., Li Y., Li J., Li X., and Wang H. ERK-dependent signaling pathway and transcriptional factor Ets-1 regulate matrix metalloproteinase-9 production in transforming growth factor-beta1 stimulated glomerular podocytes. Cell. Physiol. Biochem. 16 (2005) 207-216
36. Hida M., Omori S., and Awazu M. ERK and p38 MAP kinase are required for rat renal development. Kidney Int. 61 (2002) 1252-1262
37. Bokemeyer D., Guglielmi K.E., McGinty A., Sorokin A., Lianos E.A., and Dunn M.J. Activation of extracellular signal-regulated kinase in proliferative glomerulonephritis in rats. J. Clin. Invest. 100 (1997) 582-588
38. Renlund N., Jo Y., Svechnikova I., Holst M., Stocco D.M., Soder O., and Svechnikov K. Induction of steroidogenesis in immature rat Leydig cells by interleukin-1alpha is dependent on extracellular signal-regulated kinases. J. Mol. Endocrinol. 36 (2006) 327-336
39. Martinat N., Crepieux P., Reiter E., and Guillou F. Extracellular signal-regulated kinases (ERK), 1 2 are required for luteinizing hormone (LH)-induced steroidogenesis in primary Leydig cells and control steroidogenic acute regulatory (StAR) expression. Reprod. Nutr. Dev. 45 (2005) 101-108
40. Muller D., Cortes-Dericks L., Budnik L.T., Brunswig-Spickenheier B., Pancratius M., Speth R.C., Mukhopadhyay A.K., and Middendorff R. Homologous and lysophosphatidic acid-induced desensitization of the atrial natriuretic peptide receptor, guanylyl cyclase-A, in MA-10 leydig cells. Endocrinology 147 (2006) 2974-2985
41. Tanoue T., Adachi M., Moriguchi T., and Nishida E. A conserved docking motif in MAP kinases common to substrates activators and regulators. Nat. Cell Biol. 2 (2000) 110-116
42. Tanoue T., Maeda R., Adachi M., and Nishida E. Identification of a docking groove on ERK and p38 MAP kinases that regulates the specificity of docking interactions. Embo. J. 20 (2001) 466-479
43. Farooq A., Chaturvedi G., Mujtaba S., Plotnikova O., Zeng L., Dhalluin C., Ashton R., and Zhou M.M. Solution structure of ERK2 binding domain of MAPK phosphatase MKP-3: structural insights into MKP-3 activation by ERK2. Mol. Cell 7 (2001) 387-399
44. Stewart A.E., Dowd S., Keyse S.M., and McDonald N.Q. Crystal structure of the MAPK phosphatase Pyst1 catalytic domain and implications for regulated activation. Nat. Struct. Biol. 6 (1999) 174-181
45. Sebolt-Leopold J.S., and Herrera R. Targeting the mitogen-activated protein kinase cascade to treat cancer. Nat. Rev., Cancer 4 (2004) 937-947
46. Kohno M., and Pouyssegur J. Targeting the ERK signaling pathway in cancer therapy. Ann. Med. 38 (2006) 200-211